UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of ( ...

GMM Reported Revenue (Pre-Acquisition) 6,487 Consolidated Pro Forma Revenue $2,510,880 Twelve Months Ended Dec 31, | --- | --- | |-------|----------| | 2022 | | | | $221,902 | | | | | | $224,351 | (dollars in thousands) Consolidated Adj. EBITDA Consolidated Pro Forma Adj. EBITDA | --- | --- | |---------------------------------------------------------|---------------| | | | | Pro Forma Remote Patient Monitoring Segment Revenue | Twelve Months | | | Ended Dec 31, | | (dollars in thousands) | 2022 | | Modivcar ...

ModivCare Inc. (NASDAQ:MODV) Q1 2023 Earnings Conference Call May 4, 2023 8:00 AM ET Company Participants Kevin Ellich - Head, Investor Relations Heath Sampson - President, Chief Executive Officer and Chief Financial Officer Ken Shepard - Head of Finance Conference Call Participants Brian Tanquilut - Jefferies Bob Labick - CJS Securities Scott Fidel - Stephens Pito Chickering - Deutsche Bank Miles Highsmith - Deutsche Bank Mike Petusky - Barrington Research Operator Good morning and welcome to ModivCare's F ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of ...

|██ modivcare Forward Looking Statements In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), this investor presentation includes presentations of EBITDA, Adjusted EBITDA, and Adjusted EBITDA margin for the Company and its segments, pro forma presentations of such financial measures that adjust for the acquisitions identified herein, and EBITDA and Adjusted EBITDA for the Company's Matrix equity investment, which are perfor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-34221 ModivCare Inc. (Exact name of registrant as specified in its charter) Delaware 86-0845127 (State or other jurisdiction of (I.R. ...

ModivCare Inc. (NASDAQ:MODV) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET Company Participants Kevin Ellich - Head, IR Heath Sampson - President, Chief Executive Officer and Chief Financial Officer Kenneth Shepard - CFO of Mobility Scott Kern - CFO of Home Conference Call Participants Brian Tanquilut - Jefferies Peter Lukas - CJS Securities Brooks O'Neil - Lake Street Capital Scott Fidel - Stephens Inc. Kieran Ryan - Deutsche Bank Michael Petusky - Barrington Research Operator Good morni ...

ModivCare Inc. (NASDAQ:MODV) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Kevin Ellich - Head, IR Heath Sampson - President, Chief Executive Officer and Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Bob Labick - CJS Securities Brooks O'Neil - Lake Street Capital Pito Chickering - Deutsche Bank Mike Petusky - Barrington Research Operator Good morning, and welcome to ModivCare's Third Quarter 2022 Financial Results Conference Call. At thi ...

Investor Presentation November 2022 Copyright © 2022 Modivcare® Inc. Forward Looking Statements Certain statements contained in this presentation constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. The ...

ModivCare Inc. (NASDAQ:MODV) Q2 2021 Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Kevin Ellich - Head of Investor Relations Heath Sampson - Interim Chief Executive Officer and Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Bob Labick - CJS Securities Scott Fidel - Stephens Inc. Brooks O'Neil - Lake Street Capital Markets Kieran Ryan - Deutsche Bank Mike Petusky - Barrington Research Operator Good morning, and welcome to ModivCare's Second Quarter ...